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From July 2003 through October 2004, 42 patients 
became infected by strains of Leuconostoc mesenteroides 
subsp. mesenteroides (genotype 1) in different departments 
of Juan Canalejo Hospital in northwest Spain. During 2006, 
6 inpatients, also in different departments of the hospital, 
became infected (genotypes 2–4). Parenteral nutrition was 
the likely source.
L
euconostoc species are catalase-negative, gram-pos-
itive microorganisms with coccoid morphology (1). 
In 1985, Buu-Hoi et al. (2) reported the ﬁ  rst cases of Leu-
conostoc infection in humans. Since then, Leuconostoc 
spp. have been implicated in a variety of infections (3–8), 
particularly in patients being treated with vancomycin and 
in immunocompromised patients. However, these species 
have never previously been considered as agents that cause 
severe hospital outbreaks that threaten the lives of large 
numbers of persons.
Between July 2003 and October 2004, and between 
August and November 2006, 42 and 6 patients, respec-
tively (Figure 1), in the Juan Canalejo Hospital (a tertiary-
level, 1,400-bed hospital serving a population of 516,000 
in La Coruña, northwest Spain) became infected by a strain 
of Leuconostoc mesenteroides subsp. mesenteroides (LM). 
The patients had been admitted to 13 different, physically 
separated departments in the hospital (3 different hospital 
buildings), and 11 of the 48 were newborns. The aims of 
the present study were to characterize the epidemiologic 
features of the outbreak and to determine the risk factors 
associated with the infection.
The Study
All bacterial isolates related to the outbreaks (1 per 
patient) were obtained from clinical samples. The strains 
were identiﬁ   ed phenotypically by rapid ID 32 STREP 
(bioMérieux, Marcy l’Etoile, France), which yielded pro-
ﬁ  le 22025001100 (Leuconostoc spp. 99.9%) and BIOLOG 
GP2 panels (Biolog, Hayward, CA, USA) (98%, T  = 
0.708). The results were conﬁ  rmed by 16S rDNA sequence 
analysis, by a previously reported method (9), and the anal-
ysis of 1,420–1,500 bp showed 99% probability that the 
species were LM, when compared with GenBank database 
sequences.
Antimicrobial drug susceptibility was determined by 
microdilution, with DadeMicroscan system (Baxter Health 
Care, West Sacramento, CA, USA), and MICs were con-
ﬁ  rmed by E-test (AB Biodisk, Solna, Sweden). For inter-
pretation of antimicrobial drug susceptibility, Clinical and 
Laboratory Standards Insitute criteria (10) for Leuconostoc 
spp. or when appropriate Streptococcus spp. other than S. 
pneumoniae, were used. The antimicrobial drug suscepti-
bility proﬁ  les were almost identical for all genotypes and 
showed susceptibility to penicillin and gentamicin (MICs 
of 0.25 mg/L and <2 mg/L, respectively) and to levoﬂ  oxa-
cin, tetracycline, quinupristin-dalfopristin, linezolid, dapto-
mycin, erythromycin, clindamycin, and chloramphenicol.
A pulsed-ﬁ  eld gel electrophoresis (PFGE) technique 
was used to assess the possibility of a clonal relationship 
among the 48 LM strains. Genomic DNA was extracted, re-
stricted with ApaI, and electrophoresed with CHEF-DRIII 
apparatus (Bio-Rad Laboratories, Richmond, CA, USA). 
The isolates were classiﬁ  ed epidemiologically, according 
to published criteria (11). No differences in the band proﬁ  le 
were observed among the 42 strains of the ﬁ  rst outbreak 
(genotype 1). Analysis of the 6 strains isolated in the 2006 
outbreak showed different DNA band patterns from those 
corresponding to genotype 1 (Figure 2). Of the 6 isolates, 4 
shared the same genotype, designated genotype 2, whereas 
the remaining 2 isolates showed 2 new genotypes (geno-
types 3 and 4). One LM strain, isolated from the parenteral 
nutrition catheter of a patient involved in the 2006 outbreak 
(genotype 2), was identical to those isolated from blood of 
the same patient (Figure 2) and from 3 other patients in-
volved in the 2006 outbreak (data not shown).
Most of the 42 patients infected with LM genotype 1 
in the ﬁ  rst outbreak displayed severe underlying diseases 
(Table 1); 9 of the patients died, and 3 of the deaths (7.1%) 
were directly related to the Leuconostoc infection. The bac-
terial isolates were isolated from blood (52.1%), catheter 
(21.8%), or both (26.1%).
To assess risk factors related to acquisition of LM 
strains, we performed a case–control study. The ﬁ  rst 42 
patients (2003–2004) were designated as case-patients. 
Control-patients (n = 61) were randomly selected among 
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remaining patients with another nosocomial infection 
caused by a non–Leuconostoc spp. microorganism iso-
lated from a catheter, blood, or both, who were admitted 
to the same department and at the same time as the pa-
tients deﬁ  ned as case-patients. The variables analyzed are 
shown in Table 2.
Nosocomial infection criteria were those previously 
established by the Centers for Disease Control and Preven-
tion (Atlanta, GA, USA) (12). A multiple logistic regres-
sion model was developed to identify potential independent 
factors associated with acquisition of LM strains. Predictor 
variables with p<0.10 in univariate analysis were included 
in the multivariate model to enable adjustment. Statistical 
analyses were conducted with SPSS 14.0 software (SPSS 
Inc., Chicago, IL, USA).
According to the multivariate analysis, previous infec-
tions (38.2% were bacteremias) (odds ratio [OR] = 4.2) and 
parenteral nutrition (OR = 27.8) were associated with Leu-
conostoc spp. infection (Table 2). After the case–control 
study, parenteral nutrition was suspected to be the source 
of the outbreak.
All case-patients received parenteral nutrition, with 
the exception of 2, although they received enteral nutri-
tion. Parenteral nutrition is a putative source of the in-
fection because all parenteral and enteral nutrition bags 
are prepared in the central hospital pharmacy and then 
distributed to the different medical units in the hospital. 
This possibility was further supported by 1 ﬁ  nding: PFGE 
analysis of isolates obtained from a parenteral nutrition 
catheter connected to a patient during the second outbreak 
yielded the same genotype as the isolates obtained from 
blood from the same patient (Figure 2) and from another 3 
physically separated, infected patients. The physical dis-
tance between these patients as well as the impossibility 
of retrograde displacement of the bacterial isolate from 
patient’s blood makes it unlikely that the LM strain was 
acquired by contamination from the blood and indicates 
parenteral nutrition as the main source of LM transmis-
sion in the hospital outbreak. Microbiologic controls of 
parenteral nutrition were reinforced during the second 
outbreak, and as stated, only 6 cases were detected. More-
over, during the second outbreak, microbiologic analysis 
  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 14, No. 6, June 2008  969 
Figure 1. Epidemic curve of distribution 
of  Leuconostoc-infected patients 
throughout the period of study. Two 
different outbreak periods were 
detected, July 2003 through October 
2004 (42 patients) and August through 
November 2006 (6 patients). The ﬁ  rst 
outbreak period was caused by a 
single epidemic strain and the second 
one was caused by 3 different strains. 
Figure 2. Band pattern obtained by pulsed-ﬁ  eld gel electrophoresis of selected Leuconostoc mesenteroides subsp. mesenteroides (LM) 
isolates. Mw, molecular weight marker at indicated sizes; lines 1 to 9, representative LM isolates from the ﬁ  rst outbreak (genotype 1); 
lines 10, 11, LM isolates obtained from parenteral nutrition catheter and blood from the same patient (genotype 2) and identical to those 
from 3 different patients infected in the second outbreak (data not shown); lines 12, 13, LM isolates from 2 different patients involved in 
the second outbreak (genotypes 3 and 4)of environmental samples as well as samples from the di-
gestive tract, skin, and throat of all patients involved did 
not yield any Leuconostoc strains.
Parenteral nutrition controls performed in the hospital 
pharmacy department are now routinely assayed for LM 
isolation. Since the last LM outbreak in November 2006, 
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Table 1. Clinical features of the case-control patients in the first outbreak of Leuconostoc mesenteroides subsp. mesenteroides 
infection, La Coruña, Spain, 2003–2004 
Diagnosis* No. cases (%), n = 42  No. controls (%), n = 61 
Newborns  11 (26.2)   17 (27.9) 
Adults (>1 y)  31 (73.8)  44 (72.1) 
Tumors 
  Solid  9 (21.4)  13 (21.31) 
  Leukemia/lymphoma/myeloma  1/5/0 (2.38/11.9/0)  3/4/3 (4.92/6.56/4.92) 
Digestive tract disease 
 Pancreatitis  3  (7.14)  0
  Necrotizing enterocolitis  2 (4.76)  1 (1.64) 
  Ulcerous colitis/Crohn disease  1/1 (2.38/2.38)  0/1 (0/1.64) 
  Cholecystitis  2 (4.76)  1 (1.64) 
  Bowel perforation  3 (7.14)  0
  Bowel atresia  2 (4.76)  1 (1.64) 
  Bowel fistula  2 (4.76)  1 (1.64) 
Prematurity  3 (7.14)  11 (18.03) 
Infections† 3 (7.14)  2 (3.28) 
Cardiopathy  2 (4.76)  3 (4.92) 
Chylothorax 4  (9.52)  0
Brain vascular disease  3 (7.14)   8 (13.11) 
Immunosupression 18 (48.9)  36 (59.0) 
Others 3 (7.14)  9 (14.75) 
*Each patient may have >1 diagnosis. 
†Concomitant with Leuconostoc infection. 
Table 2. Model for predicting infection by L. mesenteroides subsp. mesenteroides (LM), La Coruña, Spain, 2003–2004* 
Cases, n = 42  Controls, n = 61 
Variable No. (%)
Mean
(SD) No. (%)
Mean
(SD)
Crude OR†  
(95% CI) 
Adjusted OR 
(95% CI)  p value 
Age, y 34.3
(28.2)
44.4
(31.7)
0.99 (0.98–1.0) 
Time between admission and 
infection
33.5
(38.4)
37.5
(100.9)
0.999 (0.994–1.0)  NS
Charlson score 2.94
(2.13)
4.28
(2.38)
0.76 (0.61–0.96)  NS
Previous surgery 29 (69)  23 (37.7)  3.7 (1.6–8.5)  NS
Previous infections 31 (73.8)  15 (24.6)  8.6 (3.5–21.3)  4.2 (1.2–14.7)  0.023
Previous antimicrobial drug therapy 37 (88.1)  42 (68.9)  3.3 (1.1–9.9)  NS
 Teicoplanin 12 (28.6)  4 (6.6)  5.7 (1.7–19.2)  NS
 Vancomycin 5 (11.9)  3 (4.9)  2.6 (0.6–11.6) 
Central venous lines 39 (92.9)  41 (67.2)  6.3 (1.7–23.0)  NS
Sex
  Male 24 (57.1)  41 (67.2)  0.7 (0.3–15) 
Urinary catheter 28 (66.7)  21 (34.4)  3.7 (1.6–8.6)  NS
Enteral nutrition 18 (42.9)  23 (37.7)  1.2 (0.6–2.8) 
Parenteral nutrition 40 (95.2)  26 (42.6)  26.9 (6–121.6)  27.8 (5.5–141.1)  <0.000
Blood transfusion 24 (57.1)  31 (50.8)  1.3 (0.6–2.8) 
Intubation 18 (42.9)  17 (27.9)  1.9 (0.8–4.4) 
Tracheostomy 4 (9.5)  3 (4.9)  2.0 (0.4–9.6) 
Treatment with steroids 8 (19)  12 (19.7)  1 (0.4–2.6) 
Alteration of gastrointestinal barrier‡ 29 (69)  30 (49.2)  2.3 (1.0–5.3)   NS 
*Values for 42 case patients and 61 control patients. SD, standard deviation; OR, odds ratio; CI, confidence interval; NS, variable did not meet criterion for 
remaining in the multivariate model. All these variables were considered as potential risk factors for LM infection. The LM infection was considered as an 
outcome variable. 
†Predictor variables with p<0.10 in univariate analysis were included in the multivariate model to enable simultaneous adjustment. 
‡Any process that modifies the gastrointestinal barrier (inflammation, atresia, resection, obstruction). Leuconostoc mesenteroides Outbreaks
no cases of Leuconostoc-associated bacteremia have been 
reported in the hospital.
Conclusions
That 42 LM isolates from the ﬁ  rst outbreak shared the 
same genotype and 4 of 6 isolates in the second outbreak 
also shared the same (another) genotype rules out the pos-
sibility of endogenous infections among patients and sug-
gests a common source for each outbreak. The occurrence 
of cases in patients in areas that were physically separated 
rules out the possibility of indirect patient-to-patient spread 
through the hands of healthcare workers or contaminated 
hospital equipment (different departments do not share 
healthcare workers and equipment). 
Enteral and parenteral nutrition has previously been 
described (13,14) as a risk factor associated with Leuconos-
toc-infections, although no microbiologic evidence was 
provided in any of the studies. With regard to previous in-
fections in the multiple logistic regression model, this may 
be related to the alteration of the immune system caused 
by the microorganism that caused the previous infections. 
This alteration may play a role facilitating the subsequent 
Leuconostoc spp. infection.
Two previous reports have described hospital trans-
mission of Leuconostoc spp (7,15); both outbreaks affected 
a small number of patients, and no epidemiologic studies 
were conducted to clarify the genetic relationship among 
the bacterial strains involved or the source of the nosoco-
mial infection. Although up to 88 cases of Leuconostoc in-
fection have been reported in the scientiﬁ  c literature in the 
past 25 years, these cases may not be comparable to those 
reported here, the largest nosocomial outbreak caused by 
Leuconostoc spp. worldwide.
This outbreak highlights the importance of LM as an 
emerging hospital pathogen in patients with underlying dis-
eases and in whom parenteral nutrition may be the source 
of the initial infection and its spread. Every infection with 
LM could be a yet undetected outbreak and should result 
in an investigation that focuses on parenteral nutrition or 
products manufactured in a centralized hospital pharmacy.
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